208 related articles for article (PubMed ID: 21693658)
1. Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.
Ugras S; Brill E; Jacobsen A; Hafner M; Socci ND; Decarolis PL; Khanin R; O'Connor R; Mihailovic A; Taylor BS; Sheridan R; Gimble JM; Viale A; Crago A; Antonescu CR; Sander C; Tuschl T; Singer S
Cancer Res; 2011 Sep; 71(17):5659-69. PubMed ID: 21693658
[TBL] [Abstract][Full Text] [Related]
2. miR-193b-Regulated Signaling Networks Serve as Tumor Suppressors in Liposarcoma and Promote Adipogenesis in Adipose-Derived Stem Cells.
Mazzu YZ; Hu Y; Soni RK; Mojica KM; Qin LX; Agius P; Waxman ZM; Mihailovic A; Socci ND; Hendrickson RC; Tuschl T; Singer S
Cancer Res; 2017 Nov; 77(21):5728-5740. PubMed ID: 28882999
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
[TBL] [Abstract][Full Text] [Related]
4. Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma.
Fricke A; Cimniak AFV; Ullrich PV; Becherer C; Bickert C; Pfeifer D; Heinz J; Stark GB; Bannasch H; Braig D; Eisenhardt SU
Cancer Biomark; 2018; 22(2):199-207. PubMed ID: 29689704
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.
Zaragosi LE; Dadone B; Michiels JF; Marty M; Pedeutour F; Dani C; Bianchini L
Carcinogenesis; 2015 Jan; 36(1):32-40. PubMed ID: 25344834
[TBL] [Abstract][Full Text] [Related]
7. MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
Zhang P; Bill K; Liu J; Young E; Peng T; Bolshakov S; Hoffman A; Song Y; Demicco EG; Terrada DL; Creighton CJ; Anderson ML; Lazar AJ; Calin GG; Pollock RE; Lev D
Cancer Res; 2012 Apr; 72(7):1751-62. PubMed ID: 22350414
[TBL] [Abstract][Full Text] [Related]
8. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.
Hisaoka M; Matsuyama A; Nakamoto M
Am J Pathol; 2012 May; 180(5):2076-83. PubMed ID: 22429966
[TBL] [Abstract][Full Text] [Related]
9. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.
Kapodistrias N; Mavridis K; Batistatou A; Gogou P; Karavasilis V; Sainis I; Briasoulis E; Scorilas A
Oncotarget; 2017 Jan; 8(4):6896-6913. PubMed ID: 28036291
[TBL] [Abstract][Full Text] [Related]
10. Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma.
Dang TN; Tiongco RP; Brown LM; Taylor JL; Lyons JM; Lau FH; Floyd ZE
BMC Cancer; 2022 Mar; 22(1):300. PubMed ID: 35313831
[TBL] [Abstract][Full Text] [Related]
11. A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.
Yu PY; Balkhi MY; Ladner KJ; Alder H; Yu L; Mo X; Kraybill WG; Guttridge DC; Iwenofu OH
Lab Invest; 2016 Apr; 96(4):481-91. PubMed ID: 26878133
[TBL] [Abstract][Full Text] [Related]
12. Induction of p53-independent apoptosis by ectopic expression of HOXA5 in human liposarcomas.
Lee DH; Forscher C; Di Vizio D; Koeffler HP
Sci Rep; 2015 Jul; 5():12580. PubMed ID: 26219418
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1.
Kanojia D; Kirtonia A; Srujana NSV; Jeevanandan SP; Shyamsunder P; Sampath SS; Dakle P; Mayakonda A; Kaur H; Yanyi J; Koeffler HP; Garg M
Pharmacol Res; 2022 Nov; 185():106462. PubMed ID: 36167276
[TBL] [Abstract][Full Text] [Related]
14. ZIC1 overexpression is oncogenic in liposarcoma.
Brill E; Gobble R; Angeles C; Lagos-Quintana M; Crago A; Laxa B; Decarolis P; Zhang L; Antonescu C; Socci ND; Taylor BS; Sander C; Koff A; Singer S
Cancer Res; 2010 Sep; 70(17):6891-901. PubMed ID: 20713527
[TBL] [Abstract][Full Text] [Related]
15. miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFβ, and Wnt signaling.
Mazzu YZ; Hu Y; Shen Y; Tuschl T; Singer S
Sci Rep; 2019 Mar; 9(1):3197. PubMed ID: 30824765
[TBL] [Abstract][Full Text] [Related]
16. Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas.
Taylor BS; DeCarolis PL; Angeles CV; Brenet F; Schultz N; Antonescu CR; Scandura JM; Sander C; Viale AJ; Socci ND; Singer S
Cancer Discov; 2011 Dec; 1(7):587-97. PubMed ID: 22328974
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of dicer and mir-155 expression in liposarcoma.
Vincenzi B; Iuliani M; Zoccoli A; Pantano F; Fioramonti M; De Lisi D; Frezza AM; Rabitti C; Perrone G; Onetti Muda A; Russo A; Giordano A; Santini D; Dei Tos AP; Tonini G
Oncotarget; 2015 Apr; 6(12):10586-91. PubMed ID: 25888631
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis.
Gobble RM; Qin LX; Brill ER; Angeles CV; Ugras S; O'Connor RB; Moraco NH; Decarolis PL; Antonescu C; Singer S
Cancer Res; 2011 Apr; 71(7):2697-705. PubMed ID: 21335544
[TBL] [Abstract][Full Text] [Related]
19. Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis.
Wu YV; Okada T; DeCarolis P; Socci N; O'Connor R; Geha RC; Joy Somberg C; Antonescu C; Singer S
Genes Chromosomes Cancer; 2012 Apr; 51(4):313-27. PubMed ID: 22170698
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.
Koo KH; Kwon H
Cell Death Dis; 2018 Jan; 9(2):77. PubMed ID: 29362401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
